DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹47,594 Cr | ₹37,806 Cr | ₹31,580 Cr | ₹28,470 Cr | ₹25,548 Cr |
What is the latest Total Liabilities ratio of DR REDDYS LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹47,594 Cr |
| Mar2024 | ₹37,806 Cr |
| Mar2023 | ₹31,580 Cr |
| Mar2022 | ₹28,470 Cr |
| Mar2021 | ₹25,548 Cr |
How is Total Liabilities of DR REDDYS LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹47,594 Cr | 25.89 | |
| Mar2024 | ₹37,806 Cr | 19.72 | |
| Mar2023 | ₹31,580 Cr | 10.92 | |
| Mar2022 | ₹28,470 Cr | 11.44 | |
| Mar2021 | ₹25,548 Cr | - | |
Compare Total Liabilities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹108,619.5 Cr | 1.1% | -2.1% | -5.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,148.0 Cr | 3.5% | -1.5% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,009.0 Cr | 1.1% | -1.1% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,779.0 Cr | -0.2% | -0.3% | 35% | Stock Analytics | |
| CIPLA | ₹115,772.0 Cr | 3.1% | 1% | -11.3% | Stock Analytics | |
| MANKIND PHARMA | ₹104,478.0 Cr | 7.7% | 0.9% | 2.1% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 1.1% |
-2.1% |
-5.6% |
| SENSEX | -0.8% |
1.4% |
-6.8% |
You may also like the below Video Courses